LUNESTA - For Healthcare Professionals: About the Rest for Less Program

FOR HEALTHCARE PROFESSIONALS

SITE MAP

Lunesta Rest For Less Savings Program^TM

The Lunesta Rest For Less Savings Program^TM is designed to help Lunesta patients reduce their copay. Patients may save up to $50.00 on each of their next 12 prescriptions/refills each calendar year; a savings of up to $600.00 per calendar year!

Patients can receive a Lunesta Rest For Less Savings Program^TM card through their physician, by calling 1-888-394-7377 or by visiting www.lunesta.com. Patients activate the card through www.lunesta.com or by calling 866-620-2195.

Rest For Less Savings Program Image

* Reproduction of card image

Program Rules -- Patient Eligibility, Terms, and Conditions

Valid only for qualified customers with a valid prescription for LUNESTA. No substitutions permitted.
Patient must be eighteen (18) years of age or older.
Not valid for prescriptions covered or paid for by Medicare (including True-Out-of-Pocket Expenses under Medicare Part D), Medicaid, VA, DOD, Tricare or any other federal or state healthcare programs, such as state pharmaceutical assistance programs.
Not valid for patients who are Medicare eligible and enrolled in an employer-sponsored health plan or prescription drug benefit program for retirees (i.e. you are eligible for Medicare Part D but receive a prescription drug benefit through a former employer).
Discount with Lunesta Rest for Less Savings Program Savings Program Card is valid for up to a $50 discount per prescription for LUNESTA or the amount of your copay, whichever is less. Total annual savings is up to $600. Discount available on up to twelve (12) prescriptions for LUNESTA® per calendar year.
Acceptance of this offer must be consistent with the terms of any drug benefit provided by a health insurer, health plan, or other third party payor, and you agree to report acceptance of this offer to your health insurer, health plan, or third party payor as may be required.
Offer limited to one card per person and may not be used with any other discount, coupon or offer.
A minimum patient requirement for participation in the program is activated Lunesta Rest for Less Savings Program Savings Program ID number.
An original Lunesta Rest for Less Savings Program Savings Program Card or web generated paper card will be accepted and must be presented to your pharmacist at the time you have the prescription filled - not valid if reproduced.
Offer valid only in the United States including Puerto Rico. Void where prohibited by law, taxed or restricted.
Sepracor Inc. reserves the right to change or discontinue this offer at any time without notice.
This card may not be sold, purchased or traded, or offered for sale, purchase or trade.

Lunesta^® (eszopiclone) is indicated for the treatment of insomnia. In controlled outpatient and sleep laboratory studies, LUNESTA administered at bedtime decreased sleep latency and improved sleep maintenance.

IMPORTANT SAFETY INFORMATION:
The failure of insomnia to remit after 7 to 10 days of treatment may indicate the presence of a primary psychiatric and/or medical illness that should be evaluated.

Rare cases of angioedema, and additional symptoms suggesting anaphylaxis, have been reported in patients after taking sedative-hypnotics, including LUNESTA. Patients who experience such reactions should not be rechallenged with the drug.

A variety of abnormal thinking and behavior changes, such as decreased inhibition, bizarre behavior, agitation and hallucinations have been reported to occur in association with the use of sedative/hypnotics. Complex behaviors such as "sleep driving," preparing and eating food, making phone calls, or having sex while not fully awake, with amnesia for the event, have been reported. The use of alcohol and other CNS depressants appears to increase the risk of such behaviors. The emergence of any new behavioral sign or symptom requires immediate evaluation. Discontinuation of LUNESTA should be strongly considered who report a sleep driving episode.

Sedative/hypnotic drugs should be administered with caution to patients exhibiting signs and symptoms of depression. In primarily depressed patients, worsening of depression, including suicidal thoughts and actions (including completed suicides) have been reported in association with the use of sedative/hypnotics. Intentional overdose is more common in this group of patients; therefore, the least amount of drug that is feasible should be prescribed for the patient at any one time.

Sedative hypnotics have produced withdrawal signs and symptoms following abrupt discontinuation. Use of benzodiazepines and similar agents may lead to physical and psychological dependence. The risk of abuse and dependence increases with the dose and duration of treatment and concomitant use of other psychoactive drugs. The risk is also greater for patients who have a history of alcohol or drug abuse or history of psychiatric disorders. These patients should be carefully monitored.

LUNESTA, like other hypnotics, has CNS-depressant effects. Because of the rapid onset of action, LUNESTA should only be ingested immediately prior to going to bed or after the patient has gone to bed and has experienced difficulty falling asleep. Patients receiving LUNESTA should be cautioned against engaging in hazardous occupations requiring complete mental alertness or motor coordination (e.g., operating machinery or driving a motor vehicle) after taking the drug, including potential impairment of the performance of such activities that may occur the following day. Dose adjustment may be necessary when LUNESTA is co-administered with other CNS-depressants due to potential additive effects. LUNESTA should not be taken with alcohol.

In clinical trials, the most common adverse events associated with LUNESTA were unpleasant taste, headache, somnolence, dizziness, dry mouth, infection, and pain.

Full Prescribing Information